Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
JCO Oncology Practice|January 23, 2024
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102Wael Saber, Aasthaa Bansal, Lily Li, et al.
Transplantation and Cellular Therapy|March 30, 2021
ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell TransplantationDoris K Hansen, Jongphil Kim, Zachary Thompson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2018
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North AmericaNandita Khera, Betty K Hamilton, Joseph A Pidala, et al.
Blood Advances|February 26, 2021
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantationNelli Bejanyan, Joseph A Pidala, Xuefeng Wang, et al.
Transplantation and Cellular Therapy|January 15, 2026
Towards Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task ForceAlina Markova, Stephanie J Lee, Badri Modi, et al.
Transplantation and Cellular Therapy|October 12, 2021
Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research AnalysisVijaya Raj Bhatt, Tao Wang, Karen Chen, et al.
Transplantation and Cellular Therapy|October 16, 2023
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Blood Advances|October 14, 2021
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host diseaseAleksandr Lazaryan, Stephanie Lee, Mukta Arora, et al.
Transplantation and Cellular Therapy|September 21, 2024
Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell TherapyAasha I Hoogland, Anna Barata, Xiaoyin Li, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Pageof 5